A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor
Author:
Affiliation:
1. Division of Hematology; The Ohio State University; Columbus OH USA
2. Division of Hematology; University of Utah; Salt Lake City UT USA
3. Department of Pathology; The Ohio State University; Columbus OH USA
Funder
Ohio State University
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15035/fullpdf
Reference26 articles.
1. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome;Dabaja;Leukaemia & Lymphoma,2001
2. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;New England Journal of Medicine,2000
3. The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma;Dunleavy;Blood,2010
4. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma;Dunleavy;New England Journal of Medicine,2013a
5. Low-intensity therapy in adults with Burkitt's lymphoma;Dunleavy;New England Journal of Medicine,2013b
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Approaches to Richter Syndrome;Clinical Lymphoma Myeloma and Leukemia;2024-09
2. Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study;The Lancet Haematology;2024-09
3. SOHO State of the Art Updates and Next Questions | Contemporary Standard of Care Therapy for Richter's Transformation and Future Directions;Clinical Lymphoma Myeloma and Leukemia;2024-07
4. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia;Blood Advances;2024-05-17
5. Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon;Expert Review of Hematology;2024-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3